Indication
Viral Respiratory Illnesses
2 clinical trials
2 products
1 drug
Product
NitazoxanideClinical trial
A Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 InfectionStatus: Completed, Estimated PCD: 2021-04-07
Product
PlaceboClinical trial
A Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF)Status: Terminated, Estimated PCD: 2021-02-01
Drug
Varlilumab